Holen Sie sich die Stockscreener-App
5.62
2.18%
0.12
Handel nachbörslich:
5.60
-0.02
-0.36%
Schlusskurs vom Vortag:
$5.50
Offen:
$5.57
24-Stunden-Volumen:
25,067
Relative Volume:
0.95
Marktkapitalisierung:
$10.77M
Einnahmen:
$7.88M
Nettoeinkommen (Verlust:
$-69.20M
KGV:
-3.071
EPS:
-1.83
Netto-Cashflow:
$-69.73M
1W Leistung:
+0.18%
1M Leistung:
-9.21%
6M Leistung:
-42.45%
1J Leistung:
-59.86%
1-Tages-Spanne:
$5.56
$5.9771
1-Wochen-Bereich:
$5.3945
$5.9771
52-Wochen-Spanne:
$5.20
$14.36
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Firmenname
Bolt Biotherapeutics Inc
Sektor
Branche
Telefon
650-665-9295
Adresse
900 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie BOLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
5.62 | 10.54M | 7.88M | -69.20M | -69.73M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | Eingeleitet | Guggenheim | Buy |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Bolt Biotherapeutics Inc Aktie (BOLT) Neueste Nachrichten
Long term hold vs stop loss in Bolt Biotherapeutics Inc.July 2025 Catalysts & Verified Momentum Stock Ideas - Newser
Is Bolt Biotherapeutics Inc. meeting your algorithmic filter criteria2025 Pullback Review & AI Driven Price Forecasts - Newser
Will Bolt Biotherapeutics Inc. bounce back from current supportQuarterly Portfolio Report & Daily Profit Focused Screening - Newser
Can technical indicators confirm Bolt Biotherapeutics Inc.’s reversalQuarterly Market Review & Verified Entry Point Signals - Newser
Multi asset correlation models including Bolt Biotherapeutics Inc.July 2025 Decliners & Weekly Top Performers Watchlists - Newser
Key metrics from Bolt Biotherapeutics Inc.’s quarterly data2025 Performance Recap & Entry Point Strategy Guides - Newser
Short interest data insights for Bolt Biotherapeutics Inc.Entry Point & High Conviction Buy Zone Picks - Newser
Is Bolt Biotherapeutics Inc. forming a bottoming basePortfolio Value Report & Risk Controlled Swing Alerts - Newser
Predicting Bolt Biotherapeutics Inc. trend using moving averagesFree Short Term Buy List With Stop Protection - Newser
Will breakout in Bolt Biotherapeutics Inc. lead to full recoveryLow Risk Stock Trade Opportunity Analysis - Newser
Using economic indicators to assess Bolt Biotherapeutics Inc. potentialAI Entry Timing Prediction for Swing Traders - Newser
Intraday pattern recognizer results for Bolt Biotherapeutics Inc.Free Entry Plan for Oversold Reversal Stocks - Newser
Why Bolt Biotherapeutics Inc. stock attracts strong analyst attentionVolume Based Swing Signal Prediction Map - Newser
Trend analysis for Bolt Biotherapeutics Inc. this weekMarket Liquidity and Price Flow Analysis - Newser
What MACD signals say about Bolt Biotherapeutics Inc.Annual Market Behavior and Sector Summary - Newser
Bolt Biotherapeutics (BOLT) Expected to Announce Earnings on Tuesday - Defense World
Bolt Biotherapeutics BOLT 2025Q2 Earnings Preview Upside Ahead on Promising Clinical Trials - AInvest
Heatmap analysis for Bolt Biotherapeutics Inc. and competitorsPortfolio Positioning Strategy With Timing - Newser
Analyzing Bolt Biotherapeutics Inc. with risk reward ratio chartsEntry Zone Forecast for Momentum Trading - Newser
How Bolt Biotherapeutics Inc. stock performs during market volatilityTechnical Trade Plan with Entry Checklist - Newser
Will earnings trigger a reversal in Bolt Biotherapeutics Inc.Entry Optimization Guide with Volume Analysis - Newser
Bolt Biotherapeutics Inc expected to post a loss of $6.45 a shareEarnings Preview - TradingView
Sector ETF performance correlation with Bolt Biotherapeutics Inc.Controlled Entry Strategy With Safety Analytics - Newser
Best data tools to analyze Bolt Biotherapeutics Inc. stockDaily Market Movers Screener with Filters - Newser
Is Bolt Biotherapeutics Inc. stock overvalued or undervaluedAchieve rapid financial growth with expert help - Jammu Links News
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):